本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

拜玛林制药

58.98
-0.1100-0.19%
盘后58.980.00000.00%19:10 EDT
成交量:141.98万
成交额:8,373.52万
市值:113.25亿
市盈率:17.35
高:59.79
开:59.23
低:58.53
收:59.09
52周最高:92.81
52周最低:52.93
股本:1.92亿
流通股本:1.78亿
量比:0.87
换手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):3.40
每股收益(LYR):2.25
净资产收益率:11.62%
总资产收益率:7.50%
市净率:1.88
市盈率(LYR):26.26

数据加载中...

2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/12

重要事件披露

Form 8-K - Current report
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

重要事件披露

Form 8-K - Current report
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/04

重要事件披露

Form 8-K - Current report
2023/11/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities